Given the importance of TERT promoter mutations in cancer development and their potential use as a biomarker for clinical outcomes and response to treatment with ICIs, we investigated the distribution of TERT promoter mutations by sex and race across different solid tumors. The gene discussed is TERT; the disease is cancer.